What is a recent exclusion criterion for the AGENT IDE trial?

• A. Recent STEMI
• B. Bifurcation lesions
• C. Thrombus in target vessel
• D. All of the above

Answer: (D)

In clinical trials, exclusion criteria are critical for determining which participants can safely and appropriately be included in the study. For the AGENT IDE trial, recent developments have specified various conditions that could complicate the outcomes or patient safety.

Recent STEMI, or ST-Elevation Myocardial Infarction, is often an exclusion criterion because individuals who have had a recent heart attack may require different medical ongoing management or might not respond as expected to the specific treatments being tested in the trial.

Bifurcation lesions, which occur at the branch points of coronary arteries, present challenges during intervention due to their complexity. Including patients with such lesions can introduce variables that would confound the results, making it difficult to isolate the effects of the treatment being studied.

Thrombus in the target vessel presents a significant risk during procedures such as coronary interventions. The presence of clot can lead to complications, such as embolization, which could skew results or impair patient safety.

By constituting a recent exclusion criterion, these factors help ensure that the trial results are more reliable and applicable to the general population without these complicating health issues. Therefore, specifying that all of these conditions are recent exclusion criteria accurately reflects the trial's aim to maintain participant safety and the integrity of the data